BlueCrest Capital Management’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-18,047
Closed -$257K 1508
2018
Q3
$257K Buy
18,047
+7,895
+78% +$107K 0.01% 1124
2018
Q2
$122K Buy
+10,152
New +$125K ﹤0.01% 1377
2017
Q3
Sell
-20,652
Closed -$264K 1134
2017
Q2
$264K Buy
20,652
+4,265
+26% +$51.8K 0.01% 714
2017
Q1
$208K Sell
16,387
-61,639
-79% -$731K 0.01% 613
2016
Q4
$797K Buy
78,026
+34,361
+79% +$392K 0.04% 405
2016
Q3
$575K Buy
+43,665
New +$584K 0.02% 484
2016
Q1
Sell
-324,548
Closed -$4.99M 1177
2015
Q4
$4.99M Buy
+324,548
New +$4.65M 0.21% 104
2015
Q3
Sell
-26,748
Closed -$366K 1083
2015
Q2
$366K Sell
26,748
-37,792
-59% -$510K 0.01% 681
2015
Q1
$772K Buy
+64,540
New +$789K 0.04% 396

Other funds holding MDRX

BlueCrest Capital Management's MDRX Position: Q4 2018 in Review

BlueCrest Capital Management sold out of Veradigm Inc. Common Stock (MDRX) in Q4 2018, closing a stake of 18,047 shares — an estimated $257K sold.

BlueCrest Capital Management first reported a position in MDRX in Q1 2015 and held it in 9 quarters. The position peaked at $4.99M in Q4 2015. 222 funds tracked by Wall St. Rank hold MDRX as of Q4 2018.

  • BlueCrest Capital Management reported no remaining Veradigm Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 18,047 Veradigm Inc. Common Stock shares in Q4 2018, an estimated $257K.
  • BlueCrest Capital Management first reported a position in Veradigm Inc. Common Stock in Q1 2015 and held it in 9 quarters.
  • BlueCrest Capital Management's Veradigm Inc. Common Stock position peaked at $4.99M in Q4 2015.
  • 222 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.